EQT/LSP Life Sciences

LSP is one of Europe’s largest and most experienced healthcare investment firms. With a track record going back more than 30 years, they have built up an investment house that is dedicated to only one task: seeking, nurturing and growing healthcare investment opportunities with the potential to have a positive impact on society. They believe such opportunities create the most value for all parties. From their offices in Amsterdam, Munich and Boston, their team aims to back the smartest inventors with the best ideas. While their goal is to develop products and technologies that have a positive impact on society, their objective is to help inventors achieve their goals. By definition, success is often accompanied by financial returns. The combination of contributing to society and the prospect of associated financial returns, is why investors entrust LSP to invest their capital alongside LSP’s own capital.

Fund information

Investment areas

LSP attracts investors from a wide range of backgrounds and origins. They all look to gain exposure to the healthcare sector via our investment funds.

Other information

Their activities as a dedicated private equity healthcare investor date back to the late 1980s. At that time, providing start-up and growth capital to innovative healthcare companies was not commonplace; in fact, they were one of the first to assume this role. Over time, they have grown to become the leader in this field in Europe. They have raised more than € 2 billion through various funds that target drug development and medical technology. Currently They manage four different fund types: LSP 7: a closed-end private equity fund investing in early-to late-stage drug development and medical technology companies; LSP HEF 2 (Health Economics Fund): a closed-end private equity fund investing in late-stage medical technology companies with a health and economic benefit; LSP Dementia: a closed-end private equity fund investing in innovative companies focusing on neurodegenerative diseases and dementia; LSP Public: an open-ended fund investing in healthcare companies listed on a stock exchange. The fund itself is listed on Euronext as LSP Life Sciences Fund with Bloomberg ticker LSP NA and ISIN Code NL0009756394.

Ways of communication
https://www.lspvc.com/contact.html

The Netherlands Johannes Vermeerplein 9 1071 DV Amsterdam T: +31 (0) 20 664 55 00 F: +31 (0) 20 676 88 10 lspamsterdam@lspvc.com Germany Dachauer Str. 65 80335 Munich T: +49 (0) 89 120 850 90 lspmunich@lspvc.com USA 303 Wyman Street, Suite 300 Waltham, MA 02451 T: +1 (781) 472-2743 F: +1 (781) 472-2642 lspboston@lspvc.com